ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 154572 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 154572; 2) Community: the network communities that were significantly associated with the response to NSC 154572; 3) Molecule: the relationships between components within communities and NSC 154572; 4) MDR: the compounds that were significantly associated with the NSC 154572.

NSC Compound Enrichment Correlation
NSC 701574 Androst-4-en-3-one, 17-ethynyl-17-hydroxy-, 3-O-[2-(1-pyrrolidinyl)ethyl]oxime, (17.beta.)- 0.00578566967432518 0.24143647
NSC 702030 4(3H)-Quinazolinone, 2,2'-thiobis[3-amino- 0.00578566967432518 0.2427107
NSC 705840 Null 0.00578566967432518 0.34099922
NSC 718729 Cyclopent-4-ene-1,3-dione, 2-[[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]methyl]- 0.00578566967432518 0.28469683
NSC 722565 Null 0.00578566967432518 0.15072419
NSC 734913 Null 0.00578566967432518 0.32255544
NSC 744115 Null 0.00578566967432518 0.074715008
NSC 745321 Null 0.00578566967432518 0.15196204
NSC 120925 Null 0.00578566967432527 -0.02083672
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.00578566967432527 0.17104968
Total:96  Current:18    [First] [Prev] [Next] [Last]